The main chemotherapeutic regimen
for osteosarcoma includes methotrexate, cisplatin,
cyclophospamide, vincristine or adriamycin.
Despite this, about 30% of these osteosarcoma
patients, which underwent standard protocol of
treatment show recurrence or metastasis during
five years period